Kimbrel, E. A. & Lanza, R. Next-generation stem cells – ushering in a new era of cell-based therapies. Nat. Rev. Drug. Discov. 19, 463–479 (2020).
Puri, M. C. & Nagy, A. Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells. 30, 10–14 (2012).
Ng, A. P. & Alexander, W. S. Haematopoietic stem cells: past, present and future. Cell Death Discov. 3, 17002 (2017).
Naji, A. et al. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol. Life Sci. 76, 3323–3348 (2019).
Tang, Y., Yu, P. & Cheng, L. Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis. 8, e3108 (2017).
Chambers, S. E. J. et al. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl. Med. 10, S54–S61 (2021).
Hoang, D. M. et al. Stem cell-based therapy for human diseases. Signal Transduct. Target Ther. 7, 272 (2022).
Zakrzewski, W., Dobrzynski, M., Szymonowicz, M. & Rybak, Z. Stem cells: past, present, and future. Stem Cell Res. Ther. 10, 68 (2019).
Zhang, K. & Cheng, K. Stem cell-derived exosome versus stem cell therapy. Nat. Rev. Bioeng. 1, 608–609 (2023).
Zhang, Y. et al. Exosome: A Review Of Its Classification, Isolation Techniques, Storage, Diagnostic And Targeted Therapy Applications. Int. J. Nanomed. 15, 6917–6934 (2020).
Vizoso, F. J. et al. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 18, 1852–1875 (2017).
Ren, K. Exosomes in perspective: a potential surrogate for stem cell therapy. Odontology. 107, 271–284 (2019).
Hastuti, S. et al. hUMSC vs. hUMSC-Exosome: which one is better for epilepsy? Pharmaceuticals. 15, 1247–1261 (2022).
Carr, N. J. The pathology of healing and repair. Surgery 40, 13–19 (2022).
Peshkova, M. et al. Targeting inflammation and regeneration: scaffolds, extracellular vesicles, and nanotechnologies as cell-free dual-target therapeutic strategies. Int. J. Mol. Sci. 23, 13796–13813 (2022).
Wang, H., Huber, C. C. & Li, X. P. Mesenchymal and neural stem cell-derived exosomes in treating alzheimeras disease. Bioengineering 10, 253–266 (2023).
Li, X. et al. Neural stem/progenitor cell-derived extracellular vesicles: a novel therapy for neurological diseases and beyond. MedComm 4, e214 (2023).
Norouzi-Barough, L., Shirian, S., Gorji, A. & Sadeghi, M. Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects. Connect Tissue Res. 63, 83–96 (2022).
Doyle, L. M. & Wang, M. Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 8, 727–750 (2019).
Pegtel, D. M. & Gould, S. J. Exosomes. Annu. Rev. Biochem. 88, 487–514 (2019).
Gurung, S., Perocheau, D., Touramanidou, L. & Baruteau, J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun. Signal. 19, 47 (2021).
Zhang, Y., Liu, Y., Liu, H. & Tang, W. H. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 9, 19 (2019).
Gholami Farashah, M. S. et al. Bone marrow mesenchymal stem cell’s exosomes as key nanoparticles in osteogenesis and bone regeneration: specific capacity based on cell type. Mol. Biol. Rep. 49, 12203–12218 (2022).
Qing, L., Chen, H., Tang, J. & Jia, X. Exosomes and their MicroRNA cargo: new players in peripheral nerve regeneration. Neurorehabilit. Neural Repair. 32, 765–776 (2018).
Kwok, Z. H., Wang, C. & Jin, Y. Extracellular vesicle transportation and uptake by recipient cells: a critical process to regulate human diseases. Processes 9, 273–294 (2021).
Kimiz-Gebologlu, I. & Oncel, S. S. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J. Control Release 347, 533–543 (2022).
Hamzah, R. N., Alghazali, K. M., Biris, A. S. & Griffin, R. J. Exosome traceability and cell source dependence on composition and cell-cell cross talk. Int. J. Mol. Sci. 22, 5346–5362 (2021).
Li, M. et al. Exosomes from different cells: characteristics, modifications, and therapeutic applications. Eur. J. Med. Chem. 207, 112784 (2020).
Shan, X. et al. The biogenesis, biological functions, and applications of macrophage-derived exosomes. Front. Mol. Biosci. 8, 715461 (2021).
Wang, Y. et al. Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases. Cell Death Dis. 11, 924 (2020).
Liu, J., Wu, F. & Zhou, H. Macrophage-derived exosomes in cancers: biogenesis, functions and therapeutic applications. Immunol. Lett. 227, 102–108 (2020).
Elashiry, M., Elsayed, R. & Cutler, C. W. Exogenous and endogenous dendritic cell-derived exosomes: lessons learned for immunotherapy and disease pathogenesis. Cells. 11, 115–136 (2021).
Pitt, J. M. et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Investig. 126, 1224–1232 (2016).
Kok, V. C. & Yu, C. C. Cancer-derived exosomes: their role in cancer biology and biomarker development. Int. J. Nanomed. 15, 8019–8036 (2020).
Naseri, M. et al. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy. Oncoimmunology 9, 1779991 (2020).
Kluszczynska, K. et al. Methods for the determination of the purity of exosomes. Curr. Pharm. Des. 25, 4464–4485 (2019).
Zhou, B. et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther. 5, 144 (2020).
Boukouris, S. & Mathivanan, S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin. Appl. 9, 358–367 (2015).
Gurunathan, S. et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 8, 307–342 (2019).
Bei, H. P. et al. Bone-a-Petite: engineering exosomes towards Bone, osteochondral, and cartilage repair. Small. 17, e2101741 (2021).
Yang, X. X., Sun, C., Wang, L. & Guo, X. L. New insight into isolation, identification techniques and medical applications of exosomes. J. Control Release 308, 119–129 (2019).
Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science. 367, 640–654 (2020).
Li, X. et al. Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy. APL Bioeng. 3, 011503 (2019).
Khayambashi, P. et al. Hydrogel encapsulation of mesenchymal stem cells and their derived exosomes for tissue engineering. Int. J. Mol. Sci. 22, 684–698 (2021).
Hussen, B. M. et al. Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy. Cancer Cell Int. 22, 323 (2022).
Shao, J., Zaro, J. & Shen, Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int. J. Nanomed. 15, 9355–9371 (2020).
Tian, Y. et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35, 2383–2390 (2014).
Kim, M. S. et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12, 655–664 (2016).
Ohno, S. et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21, 185–191 (2013).
Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341–345 (2011).
Zhu, Q. et al. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy. Adv. Sci. 6, 1801899 (2019).
Nakase, I. & Futaki, S. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci. Rep. 5, 10112 (2015).
Wu, Y., Deng, W. & Klinke, D. J. 2nd Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst. 140, 6631–6642 (2015).
Maas, S. L. et al. Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J. Control Release. 200, 87–96 (2015).
Thery, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell Vesicles. 7, 1535750 (2018).
Witwer, K. W. et al. Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles. J. Extracell Vesicles. 10, e12182 (2021).
Maroto, R. et al. Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses. J. Extracell Vesicles. 6, 1359478 (2017).
Yamashita, T., Takahashi, Y. & Takakura, Y. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol. Pharm. Bull. 41, 835–842 (2018).
Bosch, S. et al. Trehalose prevents aggregation of exosomes and cryodamage. Sci. Rep. 6, 36162 (2016).
Charoenviriyakul, C., Takahashi, Y., Nishikawa, M. & Takakura, Y. Preservation of exosomes at room temperature using lyophilization. Int. J. Pharm. 553, 1–7 (2018).
Kusuma, G. D. et al. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front. Pharmacol. 9, 1199 (2018).
Bahney, C. S. et al. Cellular biology of fracture healing. J. Orthop. Res. 37, 35–50 (2019).
Einhorn, T. A. & Gerstenfeld, L. C. Fracture healing: mechanisms and interventions. Nat. Rev. Rheumatol. 11, 45–54 (2015).
Yang, Z. et al. Exosomes: a friend or foe for osteoporotic fracture? Front. Endocrinol. 12, 679914 (2021).
Furuta, T. et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl. Med. 5, 1620–1630 (2016).
Zhang, L. et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res. Ther. 11, 38 (2020).
Jia, Y. et al. Exosomes secreted by young mesenchymal stem cells promote new bone formation during distraction osteogenesis in older rats. Calcif. Tissue Int. 106, 509–517 (2020).
Jia, Y. et al. Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis. Stem Cell Res. Ther. 10, 12 (2019).
O’Brien, K. et al. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol. 21, 585–606 (2020).
Yu, H., Zhang, J., Liu, X. & Li, Y. microRNA-136-5p from bone marrow mesenchymal stem cell-derived exosomes facilitates fracture healing by targeting LRP4 to activate the Wnt/beta-catenin pathway. Bone Joint Res. 10, 744–758 (2021).
Jiang, Y., Zhang, J., Li, Z. & Jia, G. Bone marrow mesenchymal stem cell-derived exosomal miR-25 regulates the ubiquitination and degradation of Runx2 by SMURF1 to promote fracture healing in mice. Front. Med. 7, 577578 (2020).
Wang, Y. et al. Obesity regulates miR-467/HoxA10 axis on osteogenic differentiation and fracture healing by BMSC-derived exosome LncRNA H19. J. Cell Mol. Med. 25, 1712–1724 (2021).
Behera, J., Kumar, A., Voor, M. J. & Tyagi, N. Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1/Tie2-NO signaling in CBS-heterozygous mice. Theranostics. 11, 7715–7734 (2021).
Liang, B. et al. Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway. Stem Cell Res. Ther. 10, 335 (2019).
Lu, G. D., Cheng, P., Liu, T. & Wang, Z. BMSC-derived exosomal miR-29a promotes angiogenesis and osteogenesis. Front. Cell Dev. Biol. 8, 608521 (2020).
Liu, W. et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 103, 196–212 (2020).
Katz, J. N., Arant, K. R. & Loeser, R. F. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 325, 568–578 (2021).
Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Primers. 2, 16072 (2016).
Wu, J. et al. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials 206, 87–100 (2019).
Liu, Y. et al. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle. 17, 2411–2422 (2018).
Kong, R. et al. Synovial mesenchymal stem cell-derived exosomal miR-320c enhances chondrogenesis by targeting ADAM19. Future Med. Chem. 14, 81–96 (2022).
Mao, G. et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res. Ther. 9, 247 (2018).
Tao, S. C. et al. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 7, 180–195 (2017).
Wang, R., Xu, B. & Xu, H. TGF-β1 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle 17, 2756–2765 (2018).
Zhu, Y. et al. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res. Ther. 8, 64 (2017).
Jiang, K., Jiang, T., Chen, Y. & Mao, X. Mesenchymal stem cell-derived exosomes modulate chondrocyte glutamine metabolism to alleviate osteoarthritis progression. Mediat. Inflamm. 2021, 2979124 (2021).
Huang, Y. et al. Bone marrow mesenchymal stem cell-derived exosomal miR-206 promotes osteoblast proliferation and differentiation in osteoarthritis by reducing Elf3. J. Cell Mol. Med. 25, 7734–7745 (2021).
Zhang, S. et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 156, 16–27 (2018).
Tian, X. et al. Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis. J. Cell Mol. Med. 26, 693–708 (2022).
Cho, Y. et al. Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp. Mol. Med. 53, 1689–1696 (2021).
Ding, W. et al. Spinal cord injury: the global incidence, prevalence, and disability from the global burden of disease Study 2019. Spine 47, 1532–1540 (2022).
Ahuja, C. S. et al. Traumatic spinal cord injury. Nat. Rev. Dis. Primers. 3, 17018 (2017).
Ahuja, C. S. & Fehlings, M. Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury. Stem Cells Transl. Med. 5, 914–924 (2016).
Ma, K. et al. Insulin-like growth factor-1 enhances neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism. Aging 11, 12278–12294 (2019).
Zhang, L. & Han, P. Neural stem cell-derived exosomes suppress neuronal cell apoptosis by activating autophagy via miR-374-5p/STK-4 axis in spinal cord injury. J. Musculoskelet. Neuronal Interact. 22, 411–421 (2022).
Shao, C. et al. Mesenchymal stem cell derived exosomes suppress neuronal cell ferroptosis Via lncGm36569/miR-5627-5p/FSP1 axis in acute spinal cord injury. Stem Cell Rev. Rep. 18, 1127–1142 (2022).
Nakazaki, M. et al. Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-beta upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury. J. Extracell Vesicles. 10, e12137 (2021).
Liu, W. et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J. Neuroinflamm. 17, 47 (2020).
Huang, J. H. et al. Extracellular vesicles derived from epidural fat-mesenchymal stem cells attenuate NLRP3 inflammasome activation and improve functional recovery after spinal cord injury. Neurochem. Res. 45, 760–771 (2020).
Yuan, F. et al. Endothelial progenitor cell-derived exosomes promote anti-inflammatory macrophages via SOCS3/JAK2/STAT3 axis and improve the outcome of spinal cord injury. J. Neuroinflamm. 20, 156 (2023).
Zhong, D. et al. Neural stem cell-derived exosomes facilitate spinal cord functional recovery after injury by promoting angiogenesis. Exp. Biol. Med. 245, 54–65 (2020).
Chen, J. et al. Exosomes derived from nerve stem cells loaded with FTY720 promote the recovery after spinal cord injury in rats by PTEN/AKT signal pathway. J. Immunol. Res. 2021, 8100298 (2021).
Zhu, S. et al. Versatile subtypes of pericytes and their roles in spinal cord injury repair, bone development and repair. Bone Res. 10, 30 (2022).
Zhou, Y. et al. Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis. Neural Regen. Res. 17, 194–202, (2022).
Lai, X. et al. miR-146a-5p-modified hUCMSC-derived exosomes facilitate spinal cord function recovery by targeting neurotoxic astrocytes. Stem Cell Res. Ther. 13, 487 (2022).
Li, S. et al. Exosomes derived from NGF-overexpressing bone marrow mesenchymal stem cell sheet promote spinal cord injury repair in a mouse model. Neurochem. Int. 157, 105339 (2022).
Zhou, W. et al. Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis. Stem Cell Res. Ther. 12, 174 (2021).
Perez, N. E. et al. Neurogenic bladder physiology, pathogenesis, and management after spinal cord injury. J. Pers. Med. 12, 968–982 (2022).
Vila Pouca, M. C. P., Parente, M. P. L., Jorge, R. M. N. & Ashton-Miller, J. A. Injuries in muscle-tendon-bone units: a systematic review considering the role of passive tissue fatigue. Orthop. J. Sports Med. 9, 23259671211020731 (2021).
Thomopoulos, S., Parks, W. C., Rifkin, D. B. & Derwin, K. A. Mechanisms of tendon injury and repair. J. Orthop. Res. 33, 832–839 (2015).
Nakamura, Y. et al. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett. 589, 1257–1265 (2015).
Chen, S. H. et al. Extracellular vesicles of adipose-derived stem cells promote the healing of traumatized achilles tendons. Int. J. Mol. Sci. 22, 12373–12388 (2021).
Brindisino, F. et al. Rotator cuff repair vs. nonoperative treatment: a systematic review with meta-analysis. J. Shoulder Elbow Surg. 30, 2648–2659 (2021).
Wang, C. et al. Exosomes isolated from adipose-derived stem cells: a new cell-free approach to prevent the muscle degeneration associated with torn rotator cuffs. Am. J. Sports Med. 47, 3247–3255 (2019).
Wang, C. et al. Adipose stem cell-derived exosomes decrease fatty infiltration and enhance rotator cuff healing in a rabbit model of chronic tears. Am. J. Sports Med. 48, 1456–1464 (2020).
Huang, Y. et al. Bone marrow mesenchymal stem cell-derived exosomes promote rotator cuff tendon-bone healing by promoting angiogenesis and regulating M1 macrophages in rats. Stem Cell Res. Ther. 11, 496 (2020).
Compston, J. E., McClung, M. R. & Leslie, W. D. Osteoporosis. Lancet 393, 364–376 (2019).
Ren, L. et al. Adipose mesenchymal stem cell-derived exosomes ameliorate hypoxia/serum deprivation-induced osteocyte apoptosis and osteocyte-mediated osteoclastogenesis in vitro. Biochem. Biophys. Res. Commun. 508, 138–144 (2019).
Yang, B. C. et al. Human umbilical cord mesenchymal stem cell-derived exosomes act via the miR-1263/Mob1/Hippo signaling pathway to prevent apoptosis in disuse osteoporosis. Biochem. Biophys. Res. Commun. 524, 883–889 (2020).
Yahao, G. & Xinjia, W. The role and mechanism of exosomes from umbilical cord mesenchymal stem cells in inducing osteogenesis and preventing osteoporosis. Cell Transplant. 30, 9636897211057465 (2021).
Gordon, T. Peripheral nerve regeneration and muscle reinnervation. Int. J. Mol. Sci. 21, 8652–8675 (2020).
Bucan, V. et al. Effect of exosomes from rat adipose-derived mesenchymal stem cells on neurite outgrowth and sciatic nerve regeneration after crush injury. Mol. Neurobiol. 56, 1812–1824 (2019).
Chen, J. et al. Exosomes from human adipose-derived stem cells promote sciatic nerve regeneration via optimizing Schwann cell function. J. Cell Physiol. 234, 23097–23110 (2019).
Li, C. et al. Exosomes from LPS-preconditioned bone marrow MSCs accelerated peripheral nerve regeneration via M2 macrophage polarization: involvement of TSG-6/NF-kappaB/NLRP3 signaling pathway. Exp. Neurol. 356, 114139 (2022).
Fine, N. et al. Intervertebral disc degeneration and osteoarthritis: a common molecular disease spectrum. Nat. Rev. Rheumatol. 19, 136–152 (2023).
Cheng, X. et al. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J. Cell Mol. Med. 22, 261–276 (2018).
Yu, Y. et al. Human embryonic stem-cell-derived exosomes repress NLRP3 inflammasome to alleviate pyroptosis in nucleus pulposus cells by transmitting miR-302c. Int. J. Mol. Sci. 24, 7664–7678 (2023).
Hu, Y. et al. Exosomes derived from bone mesenchymal stem cells alleviate compression-induced nucleus pulposus cell apoptosis by inhibiting oxidative stress. Oxid. Med. Cell Longev. 2021, 2310025 (2021).
Petek, D., Hannouche, D. & Suva, D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. 4, 85–97 (2019).
Liu, X. et al. Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis. Int. J. Biol. Sci. 13, 232–244 (2017).
Zuo, R. et al. Exosomes derived from human CD34(+) stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis. Stem Cell Res. Ther. 10, 321 (2019).
Campbell, B. C. V. & Khatri, P. Stroke. Lancet. 396, 129–142 (2020).
Campbell, B. C. V. et al. Ischaemic stroke. Nat. Rev. Dis. Primers. 5, 70 (2019).
Fisher, M. & Savitz, S. I. Pharmacological brain cytoprotection in acute ischaemic stroke — renewed hope in the reperfusion era. Nat. Rev. Neurol. 18, 193–202 (2022).
Luo, H. et al. miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2. Neurosci. Lett. 779, 136635 (2022).
Pan, J., Wu, T., Chen, B. & Wu, H. Exosomes derived from endothelial progenitor cells ameliorate glyoxylate deprivation (OGD)-induced neuronal apoptosis by delivering miR-221-3p. Histol. Histopathol. 38, 423–430 (2023).
Huang, R., Cheng, T. & Lai, X. Mechanism of ischemic brain injury repair by endothelial progenitor cell-derived exosomes. Mol. Med. Rep. 26, 269–278 (2022).
Zhang, G. et al. Exosomes derived from human neural stem cells stimulated by interferon gamma improve therapeutic ability in ischemic stroke model. J. Adv. Res. 24, 435–445 (2020).
Kang, X. et al. Exosomes derived from hypoxic bone marrow mesenchymal stem cells rescue OGD-induced injury in neural cells by suppressing NLRP3 inflammasome-mediated pyroptosis. Exp. Cell Res. 405, 112635 (2021).
Li, W. Y. et al. Exosomes derived from human induced pluripotent stem cell-derived neural progenitor cells protect neuronal function under ischemic conditions. Neural Regen. Res. 16, 2064–2070, (2021).
Sun, X. et al. Stem cell-derived exosomes protect astrocyte cultures from in vitro ischemia and decrease injury as post-stroke intravenous therapy. Front. Cell Neurosci. 13, 394 (2019).
Wei, R. et al. Zeb2/Axin2-Enriched BMSC-Derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity. J. Mol. Neurosci. 72, 69–81 (2022).
Wang, J. et al. Exosomes from miRNA-126-modified endothelial progenitor cells alleviate brain injury and promote functional recovery after stroke. CNS Neurosci. Ther. 26, 1255–1265 (2020).
Dong, C. et al. Mesenchymal stem cell-derived exosomes improved cerebral infarction via transferring miR-23a-3p to activate microglia. Neuromol. Med. 24, 290–298 (2022).
Zhang, Z. et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke. Aging 13, 3060–3079 (2021).
Yoon, E. J. et al. The neuroprotective effects of exosomes derived from TSG101-overexpressing human neural stem cells in a stroke model. Int. J. Mol. Sci. 23, 9532–9546 (2022).
Tian, T. et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics 11, 6507–6521 (2021).
Gao, G. et al. Induced neural stem/progenitor cell-derived extracellular vesicles promote recovery post-stroke. Clin. Transl. Med. 12, e936 (2022).
Zhu, Z. H. et al. Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke. Neural Regen. Res. 18, 404–409, (2023).
Yerrapragada, S. M. et al. The protective effects of miR-210 modified endothelial progenitor cells released exosomes in hypoxia/reoxygenation injured neurons. Exp. Neurol. 358, 114211 (2022).
Ma, X. et al. Loading MiR-210 in endothelial progenitor cells derived exosomes boosts their beneficial effects on hypoxia/reoxygeneation-injured human endothelial cells via protecting mitochondrial function. Cell Physiol. Biochem. 46, 664–675 (2018).
Pan, Q. et al. MiR-17-5p mediates the effects of ACE2-Enriched endothelial progenitor cell-derived exosomes on ameliorating cerebral ischemic injury in aged mice. Mol. Neurobiol. 60, 3534–3552 (2023).
Xu, X. et al. Combination of EPC-EXs and NPC-EXs with miR-126 and miR-210 overexpression produces better therapeutic effects on ischemic stroke by protecting neurons through the Nox2/ROS and BDNF/TrkB pathways. Exp. Neurol. 359, 114235 (2023).
Morotti, A. & Goldstein, J. N. Diagnosis and management of acute intracerebral hemorrhage. Emerg. Med. Clin. N. Am. 34, 883–899 (2016).
Li, Y. et al. miR-137 boosts the neuroprotective effect of endothelial progenitor cell-derived exosomes in oxyhemoglobin-treated SH-SY5Y cells partially via COX2/PGE2 pathway. Stem Cell Res. Ther. 11, 330 (2020).
Wiles, M. D. Management of traumatic brain injury: a narrative review of current evidence. Anaesthesia. 77, 102–112 (2022).
McKee, A. C. & Daneshvar, D. H. The neuropathology of traumatic brain injury. Handb. Clin. Neurol. 127, 45–66 (2015).
Galgano, M. et al. Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant. 26, 1118–1130 (2017).
Zhang, Y. et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J. Neurosurg. 122, 856–867 (2015).
Zhang, Y. et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem. Int. 111, 69–81 (2017).
Moore, T. L. et al. Mesenchymal derived exosomes enhance recovery of motor function in a monkey model of cortical injury. Restor. Neurol. Neurosci. 37, 347–362 (2019).
Williams, A. M. et al. Mesenchymal stem cell-derived exosomes provide neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and hemorrhagic shock. J. Neurotrauma. 36, 54–60 (2019).
Chen, Y. et al. MSC-derived exosomes promote recovery from traumatic brain injury via microglia/macrophages in rat. Aging 12, 18274–18296 (2020).
Wen, L. et al. Exosomes derived from bone marrow mesenchymal stem cells inhibit neuroinflammation after traumatic brain injury. Neural Regen. Res. 17, 2717–2724, (2022).
Abedi, M., Hajinejad, M., Atabi, F. & Sahab-Negah, S. Exosome derived from human neural stem cells improves motor activity and neurogenesis in a traumatic brain injury model. Biomed. Res. Int. 2022, 6409346 (2022).
Zhang, Y. et al. Mesenchymal stem cell-derived exosomes improve functional recovery in rats after traumatic brain injury: a dose-response and therapeutic window study. Neurorehabil. Neural Repair. 34, 616–626 (2020).
Wallace, D. J. et al. Spinal cord injury and the human microbiome: beyond the brain-gut axis. Neurosurg. Focus. 46, E11 (2019).
Kumar, S. et al. Transcriptional factors and protein biomarkers as target therapeutics in traumatic spinal cord and brain injury. Curr. Neuropharmacol. 18, 1092–1105 (2020).
Mortezaee, K., Khanlarkhani, N., Beyer, C. & Zendedel, A. Inflammasome: its role in traumatic brain and spinal cord injury. J. Cell Physiol. 233, 5160–5169 (2018).
Roselli, F., Karasu, E., Volpe, C. & Huber-Lang, M. Medusa’s head: the complement system in traumatic brain and spinal cord injury. J. Neurotrauma. 35, 226–240 (2018).
Putatunda, R., Bethea, J. R. & Hu, W. H. Potential immunotherapies for traumatic brain and spinal cord injury. Chin. J. Traumatol. 21, 125–136 (2018).
Bains, M. & Hall, E. D. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim. Biophys. Acta. 1822, 675–684 (2012).
Yuan, J. et al. Role of circular ribonucleic acids in the treatment of traumatic brain and spinal cord injury. Mol. Neurobiol. 57, 4296–4304 (2020).
Sun, P. et al. MicroRNA-based therapeutics in central nervous system injuries. J. Cereb. Blood Flow Metab. 38, 1125–1148 (2018).
Wilson, D. M. 3rd et al. Hallmarks of neurodegenerative diseases. Cell. 186, 693–714 (2023).
Erkkinen, M. G., Kim, M. O. & Geschwind, M. D. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect. Biol. 10, 3118–3163 (2018).
Breijyeh, Z. & Karaman, R. Comprehensive review on alzheimeras disease: causes and treatment. Molecules. 25, 5789–5816 (2020).
Hampel, H. et al. The amyloid-beta pathway in Alzheimer’s disease. Mol. Psychiatry. 26, 5481–5503 (2021).
Elia, C. A. et al. Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced abeta plaque burden in early stages of a preclinical model of Alzheimer’s disease. Cells. 8, 1059–1078 (2019).
Wang, S. S., Jia, J. & Wang, Z. Mesenchymal stem cell-derived extracellular vesicles suppresses inos expression and ameliorates neural impairment in Alzheimer’s disease mice. J. Alzheimers Dis. 61, 1005–1013 (2018).
Li, B. et al. Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level, and synaptic deficits in Alzheimer’s disease. J. Neurochem. 154, 502–518 (2020).
Huber, C. C. et al. Heat shock-induced extracellular vesicles derived from neural stem cells confer marked neuroprotection against oxidative stress and amyloid-beta-caused neurotoxicity. Mol. Neurobiol. 59, 7404–7412 (2022).
Chen, Y. A. et al. Mesenchymal stem cell-derived exosomes ameliorate Alzheimer’s disease pathology and improve cognitive deficits. Biomedicines. 9, 594–612 (2021).
Zavatti, M. et al. Exosomes derived from human amniotic fluid mesenchymal stem cells preserve microglia and neuron cells from Abeta. Int. J. Mol. Sci. 23, 4967–4980 (2022).
Ding, M. et al. Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer’s disease. Neurochem. Res. 43, 2165–2177 (2018).
Reza-Zaldivar, E. E. et al. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease. Neural Regen. Res. 14, 1626–1634, (2019).
Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018).
Liu, Y., Huber, C. C. & Wang, H. Disrupted blood-brain barrier in 5xFAD mouse model of Alzheimer’s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem. Biophys. Res. Commun. 525, 192–196 (2020).
Cui, G. H. et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease. Immun. Ageing. 16, 10 (2019).
Gao, G. et al. Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. Signal Transduct. Target Ther. 8, 228 (2023).
Marino, B. L. B. et al. Parkinson’s disease: a review from pathophysiology to treatment. Mini Rev, Med, Chem. 20, 754–767 (2020).
Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers. 3, 17013 (2017).
Huang, D., Zhang, M. & Tan, Z. Bone marrow stem cell-exo-derived TSG-6 Attenuates 1-Methyl-4-Phenylpyridinium+-Induced Neurotoxicity via the STAT3/miR-7/NEDD4/LRRK2 Axis. J. Neuropathol. Exp. Neurol. 81, 621–634 (2022).
Lee, E. J. et al. Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. J. Nanobiotechnol. 20, 198 (2022).
Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers. 4, 43 (2018).
Dobson, R. & Giovannoni, G. Multiple sclerosis – a review. Eur. J. Neurol. 26, 27–40 (2019).
Li, Z. et al. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int. Immunopharmacol. 67, 268–280 (2019).
Zhang, J. et al. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp. Neurol. 347, 113895 (2022).
Qi, D. et al. HNSC exosome-derived MIAT improves cognitive disorders in rats with vascular dementia via the miR-34b-5p/CALB1 axis. Am. J. Transl. Res. 13, 10075–10093 (2021).
Branscome, H. et al. Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage. Sci. Rep. 12, 2019 (2022).
Leavitt, R. J., Acharya, M. M., Baulch, J. E. & Limoli, C. L. Extracellular vesicle-derived miR-124 resolves radiation-induced brain injury. Cancer Res. 80, 4266–4277 (2020).
Smith, S. M. et al. Functional equivalence of stem cell and stem cell-derived extracellular vesicle transplantation to repair the irradiated brain. Stem Cells Transl. Med. 9, 93–105 (2020).
Long, Q. et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. Proc. Natl. Acad. Sci. USA. 114, E3536–E3545 (2017).
Li, S. et al. Bone marrow mesenchymal stem cell-derived exosomes shuttling miR-150-5p alleviates mechanical allodynia in rats by targeting NOTCH2 in microglia. Mol. Med. 28, 133 (2022).
Ma, L. et al. Neural stem cell-derived exosomal netrin1 contributes to neuron differentiation of mesenchymal stem cells in therapy of spinal bifida aperta. Stem Cells Transl. Med. 11, 539–551 (2022).
Guo, H. et al. Bone marrow mesenchymal stem cells-derived exosomes improve injury of hippocampal neurons in rats with depression by upregulating microRNA-26a expression. Int. Immunopharmacol. 82, 106285 (2020).
Niu, Y., Wang, X., Li, M. & Niu, B. Exosomes from human umbilical cord Mesenchymal stem cells attenuates stress-induced hippocampal dysfunctions. Metab. Brain Dis. 35, 1329–1340 (2020).
Natale, F. et al. Neural stem cell-derived extracellular vesicles counteract insulin resistance-induced senescence of neurogenic niche. Stem Cells 40, 318–331 (2022).
Spinelli, M. et al. Neural stem cell-derived exosomes revert HFD-dependent memory impairment via CREB-BDNF Signalling. Int. J. Mol. Sci. 21, 8994–9008 (2020).
Zhang, Y. et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548, 52–57 (2017).
Kong, L. Y. et al. Mesenchymal stem cell-derived exosomes rescue oxygen-glucose deprivation-induced injury in endothelial cells. Curr. Neurovasc. Res. 17, 155–163 (2020).
Almadani, Y. H., Vorstenbosch, J., Davison, P. G. & Murphy, A. M. Wound healing: a comprehensive review. Semin. Plast Surg. 35, 141–144 (2021).
Rodrigues, M., Kosaric, N., Bonham, C. A., Gurtner, G. C. & Wound Healing: a cellular perspective. Physiol. Rev. 99, 665–706 (2019).
Wang, M., Zhao, Y. & Zhang, Q. Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema. J. Dermatolog. Treat. 33, 1401–1405 (2022).
Cho, B. S., Kim, J. O., Ha, D. H. & Yi, Y. W. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res. Ther. 9, 187 (2018).
Qiu, X. et al. Exosomes released from educated mesenchymal stem cells accelerate cutaneous wound healing via promoting angiogenesis. Cell Prolif. 53, e12830 (2020).
Yu, M. et al. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res. Ther. 11, 350 (2020).
Ding, J. et al. Exosomes derived from human bone marrow mesenchymal stem cells stimulated by deferoxamine accelerate cutaneous wound healing by promoting angiogenesis. Biomed. Res. Int. 2019, 9742765 (2019).
Li, X., Jiang, C. & Zhao, J. Human endothelial progenitor cells-derived exosomes accelerate cutaneous wound healing in diabetic rats by promoting endothelial function. J. Diabetes Complications. 30, 986–992 (2016).
Zhang, J. et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling. Int. J. Biol. Sci. 12, 1472–1487 (2016).
Xu, J. et al. miRNA-221-3p in endothelial progenitor cell-derived exosomes accelerates skin wound healing in diabetic mice. Diabetes Metab. Syndr. Obes. 13, 1259–1270 (2020).
Zhang, W. et al. Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway. Exp. Cell Res. 370, 333–342 (2018).
Zhang, Y. et al. Adipose mesenchymal stem cell exosomes promote wound healing through accelerated keratinocyte migration and proliferation by activating the AKT/HIF-1alpha axis. J. Mol. Histol. 51, 375–383 (2020).
Kim, S., Lee, S. K., Kim, H. & Kim, T. M. Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation. Int. J. Mol. Sci. 19, 3119–3134 (2018).
He, L. et al. ADSC-Exos containing MALAT1 promotes wound healing by targeting miR-124 through activating Wnt/beta-catenin pathway. Biosci. Rep. 40, 549–561 (2020).
Gao, S. et al. Exosomal miR-135a derived from human amnion mesenchymal stem cells promotes cutaneous wound healing in rats and fibroblast migration by directly inhibiting LATS2 expression. Stem Cell Res. Ther. 11, 56 (2020).
Li, P. et al. Endothelial progenitor cell derived exosomes mediated miR-182-5p delivery accelerate diabetic wound healing via down-regulating PPARG. Int. J. Med. Sci. 20, 468–481 (2023).
Zhao, G. et al. MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing. Stem Cell Res. Ther. 11, 174 (2020).
Fang, S. et al. Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth Factor-β/SMAD2 pathway during wound healing. Stem Cells Transl. Med. 5, 1425–1439 (2016).
Hu, J., Chen, Y., Huang, Y. & Su, Y. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-beta1/Smad 2/3 signaling pathway. Exp. Mol. Pathol. 115, 104468 (2020).
Hu, L. et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci. Rep. 6, 32993 (2016).
Chen, B. et al. Human embryonic stem cell-derived exosomes promote pressure ulcer healing in aged mice by rejuvenating senescent endothelial cells. Stem Cell Res. Ther. 10, 142 (2019).
Bae, Y. U. et al. Embryonic stem cell-derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF-beta Receptor 2 pathway. J. Gerontol. A 74, 1359–1367 (2019).
Bai, Y. et al. Adipose mesenchymal stem cell-derived exosomes stimulated by hydrogen peroxide enhanced skin flap recovery in ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 500, 310–317 (2018).
Liu, Y. et al. Exosomes derived from stem cells from apical papilla promote craniofacial soft tissue regeneration by enhancing Cdc42-mediated vascularization. Stem Cell Res. Ther. 12, 76 (2021).
Li, M. et al. Mesenchymal stem cell-derived exosomes ameliorate dermal fibrosis in a Murine model of Bleomycin-Induced Scleroderma. Stem Cells Dev. 30, 981–990 (2021).
Koken, G. Y., Abamor, E. S., Allahverdiyev, A. & Karaoz, E. Wharton Jelly derived mesenchymal stem Cell’s exosomes demonstrate significant antileishmanial and wound healing effects in combination with Aloe-Emodin: an in vitro study. J. Pharm. Sci. 111, 3232–3242 (2022).
Cao, L. et al. Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100. J. Nanobiotechnol. 19, 20 (2021).
Oh, M. et al. Exosomes derived from human induced pluripotent stem cells ameliorate the aging of skin fibroblasts. Int. J. Mol. Sci. 19, 1715–1732 (2018).
Stravitz, R. T. & Kramer, D. J. Management of acute liver failure. Nat. Rev. Gastroenterol. Hepatol. 6, 542–553 (2009).
Lin, F. et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 13, 271 (2022).
Shao, M. et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res. Ther. 11, 37 (2020).
Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151–166 (2021).
Ma, L. et al. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis. Drug Deliv. 29, 440–453 (2022).
Wang, N. et al. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFbetaRII-SMADS pathway. J .Nanobiotechnol. 19, 437 (2021).
Hirao, H., Nakamura, K. & Kupiec-Weglinski, J. W. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity. Nat. Rev. Gastroenterol. Hepatol. 19, 239–256 (2022).
Yang, B. et al. Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy. Stem Cells Dev. 29, 372–379 (2020).
Du, Y. et al. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) protect liver against hepatic ischemia/ reperfusion injury via activating sphingosine kinase and Sphingosine-1-Phosphate signaling pathway. Cell. Physiol. Biochem. 43, 611–625 (2017).
Venkat, P. et al. Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice. Front. Neurosci. 17, 1061485 (2023).
Boxhoorn, L. et al. Acute pancreatitis. Lancet 396, 726–734 (2020).
Chen, M. et al. Exosomes from human induced pluripotent stem cells derived mesenchymal stem cells improved myocardial injury caused by severe acute pancreatitis through activating Akt/Nrf2/HO-1 axis. Cell Cycle. 21, 1578–1589 (2022).
Uccioli, L. et al. Critical limb ischemia: current challenges and future prospects. Vasc. Health Risk Manag. 14, 63–74 (2018).
Komaki, M. et al. Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Res. Ther. 8, 219 (2017).
Gong, M. et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget 8, 45200–45212 (2017).
Mathiyalagan, P. et al. Angiogenic Mechanisms of Human CD34(+) Stem Cell Exosomes in the Repair of Ischemic Hindlimb. Circ. Res. 120, 1466–1476 (2017).
Ye, M. et al. Exosomes derived from human induced pluripotent stem cells-endothelia cells promotes postnatal angiogenesis in mice bearing ischemic limbs. Int. J. Biol. Sci. 15, 158–168 (2019).
Lazar, A. & Morrissey, N. Recent advances in endovascular treatment of peripheral arterial disease. F1000Res. 9, 122–126 (2020).
Li, X. et al. Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function. Cytotherapy. 18, 253–262 (2016).
Hu, H. et al. Endothelial progenitor cell-derived exosomes facilitate vascular endothelial cell repair through shuttling miR-21-5p to modulate Thrombospondin-1 expression. Clin. Sci. 133, 1629–1644 (2019).
Hu, H., Jiang, C., Li, R. & Zhao, J. Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair. Int. J. Clin. Exp. Pathol. 12, 2793–2800 (2019).
Kong, J. et al. Exosomes of endothelial progenitor cells inhibit neointima formation after carotid artery injury. J. Surg. Res. 232, 398–407 (2018).
Thyoka, M. et al. Advanced necrotizing enterocolitis part 1: mortality. Eur. J. Pediatr. Surg. 22, 8–12 (2012).
McCulloh, C. J. et al. Treatment of experimental necrotizing enterocolitis with stem cell-derived exosomes. J. Pediatr. Surg. 53, 1215–1220 (2018).
Moore, L. J. et al. Sepsis in general surgery: a deadly complication. Am. J. Surg. 198, 868–874 (2009).
Zhou, Y. et al. Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis. Mol. Ther. 26, 1375–1384 (2018).
Liu, Y. et al. Protective effect of endothelial progenitor cell-derived exosomal microRNA-382-3p on sepsis-induced organ damage and immune suppression in mice. Am. J. Transl. Res. 14, 6856–6873 (2022).
Heusch, G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773–789 (2020).
Xing, X. et al. Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against atherosclerosis. Aging 12, 3880–3898 (2020).
Peng, Y. et al. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 11, 317 (2020).
Gao, L. et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci. Transl. Med. 12, 317–331 (2020).
Wen, Z. et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res. Ther. 11, 36 (2020).
Santoso, M. R. et al. Exosomes from induced pluripotent stem cell-derived cardiomyocytes promote autophagy for myocardial repair. J. Am. Heart Assoc. 9, e014345 (2020).
Katsur, M. et al. Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130. J. Cell. Mol. Med. 25, 4455–4465 (2021).
Chen, G. et al. Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy. Life Sci. 280, 119742 (2021).
Chen, F. et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling. In Vitro Cell. Dev. Biol. Anim. 56, 567–576 (2020).
Khan, M. et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117, 52–64 (2015).
Tavakoli Dargani, Z. & Singla, D. K. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. Am. J. Physiol. Heart Circ. Physiol. 317, H460–H471 (2019).
Singla, D. K., Johnson, T. A. & Tavakoli Dargani, Z. Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy. Cells. 8, 1224–1244 (2019).
Pang, Y. et al. Embryonic stem cell-derived exosomes attenuate transverse aortic constriction induced heart failure by increasing angiogenesis. Front. Cardiovasc. Med. 8, 638771 (2021).
Kervadec, A. et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J. Heart Lung Transplant. 35, 795–807 (2016).
El Harane, N. et al. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur. Heart J. 39, 1835–1847 (2018).
Li, H. et al. Exosomes secreted by endothelial cells derived from human induced pluripotent stem cells improve recovery from myocardial infarction in mice. Stem Cell. Res. Ther. 14, 278 (2023).
Li, H. et al. Isolation of swine bone marrow Lin-/CD45-/CD133 + cells and cardio-protective effects of its exosomes. Stem Cell. Rev. Rep. 19, 213–229 (2023).
Angulski, A. B. B. et al. Systemic infusion of expanded CD133(+) cells and expanded CD133(+) cell-derived EVs for the treatment of ischemic cardiomyopathy in a rat model of AMI. Stem Cells Int. 2019, 4802578 (2019).
Mackie, A. R. et al. Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ. Res. 111, 312–321 (2012).
Ke, X. et al. Human endothelial progenitor cell-derived exosomes increase proliferation and angiogenesis in cardiac fibroblasts by promoting the mesenchymal-endothelial transition and reducing high mobility Group Box 1 protein B1 expression. DNA Cell Biol. 36, 1018–1028 (2017).
Ke, X. et al. Exosomal miR-218-5p/miR-363-3p from endothelial progenitor cells ameliorate myocardial infarction by targeting the p53/JMY signaling pathway. Oxid. Med. Cell. Longev. 2021, 5529430 (2021).
Yue, Y. et al. Interleukin-10 deficiency alters endothelial progenitor cell-derived exosome reparative effect on myocardial repair via integrin-linked kinase enrichment. Circ. Res. 126, 315–329 (2020).
Liu, Q. et al. Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2. Stem Cell. Res. Ther. 14, 234 (2023).
Zhou, Y. et al. Exosomes derived from induced pluripotent stem cells suppresses M2-type macrophages during pulmonary fibrosis via miR-302a-3p/TET1 axis. Int. Immunopharmacol. 99, 108075 (2021).
Liu, P. et al. Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway. Eur. J. Pharmacol. 949, 175725 (2023).
Zhou, Y. et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Crit. Care. 23, 44 (2019).
Wu, X. et al. Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126. Exp. Cell Res. 370, 13–23 (2018).
Zhang, X. et al. Exosomes secreted by endothelial progenitor cells improve the bioactivity of pulmonary microvascular endothelial cells exposed to hyperoxia in vitro. Ann. Transl. Med. 7, 254 (2019).
Montay-Gruel, P. et al. Extracellular vesicles for the treatment of radiation-induced normal tissue toxicity in the lung. Front. Oncol. 10, 602763 (2020).
Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal. Transduct. Target Ther. 8, 129 (2023).
Liu, Y. et al. Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5. Cell Death Dis. 13, 278 (2022).
Liu, Y. et al. Bone marrow mesenchymal stem cell-derived exosomes improve renal fibrosis via regulating Smurf 2/Smad 7. Front. Biosci. 27, 17 (2022).
Lu, Y. et al. Bone marrow mesenchymal stem cell-derived exosomes improve renal fibrosis by reducing the polarisation of M1 and M2 macrophages through the activation of EP2 receptors. IET Nanobiotechnol. 16, 14–24 (2022).
Kellum, J. A. et al. Acute kidney injury. Nat. Rev. Dis. Primers. 7, 52 (2021).
Lim, S. W. et al. Alleviation of renal ischemia/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells. Korean J. Intern. Med. 37, 411–424 (2022).
Zhang, Y. et al. Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression. Cell Death Dis. 12, 335 (2021).
Sheffield, A. M. & Smith, R. J. H. The epidemiology of deafness. Cold Spring Harb Perspect. Med. 9, 3258–3273 (2019).
Tsai, S. C. et al. Umbilical cord mesenchymal stromal cell-derived exosomes rescue the loss of outer hair cells and repair cochlear damage in cisplatin-injected mice. Int. J. Mol. Sci. 22, 6664–6687 (2021).
Tabuchi, K. et al. Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species. Curr Neuropharmacol. 8, 128–134 (2010).
Hao, F. et al. Exosomes derived from microRNA-21 overexpressing neural progenitor cells prevent hearing loss from ischemia-reperfusion injury in mice via inhibiting the inflammatory process in the Cochlea. ACS Chem. Neurosci. 13, 2464–2472 (2022).
Chotigavanich, C. et al. Hypothyroidism after Hemithyroidectomy: the incidence and risk factors. J. Med. Assoc. Thai. 99, 77–83 (2016).
Degosserie, J. et al. Extracellular vesicles from endothelial progenitor cells promote thyroid follicle formation. J. Extracell. Vesicles. 7, 1487250 (2018).
Valesan, L. F. et al. Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis. Clin. Oral. Investig. 25, 441–453 (2021).
Zhang, S. et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials 200, 35–47 (2019).
Yang, Y. & Sun, X. Retinal ganglion cell death in glaucoma: advances and caveats. Curr. Eye Res. 48, 1–10 (2023).
Mead, B. & Tomarev, S. Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells. Transl. Med. 6, 1273–1285 (2017).
Van Gelder, R. N. et al. Regenerative and restorative medicine for eye disease. Nat. Med. 28, 1149–1156 (2022).
Bian, B. et al. Exosomes derived from neural progenitor cells preserve photoreceptors during retinal degeneration by inactivating microglia. J. Extracell. Vesicles. 9, 1748931 (2020).
Ke, Y. et al. Human embryonic stem cell-derived extracellular vesicles alleviate retinal degeneration by upregulating Oct4 to promote retinal Muller cell retrodifferentiation via HSP90. Stem Cell. Res. Ther. 12, 21 (2021).
Gao, Y. et al. Embryonic stem cells-derived exosomes enhance retrodifferentiation of retinal Muller cells by delivering BDNF protein to activate Wnt pathway. Immunobiology 227, 152211 (2022).
Park, U. C. et al. Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration. Ann. Transl. Med. 9, 1275 (2021).
Ong, E. S. & Jeng, B. H. Current and future therapies for persistent corneal epithelial defects and neurotrophic keratopathy. Curr. Opin. Ophthalmol. 32, 262–267 (2021).
Wang, S. et al. Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects. Aging 12, 19546–19562 (2020).
Zhu, J. et al. Role of immune cell diversity and heterogeneity in corneal graft survival: a systematic review and meta-analysis. J. Clin. Med. 10, 4667–4686 (2021).
Jia, Z. et al. Mesenchymal stem cell derived exosomes-based immunological signature in a rat model of corneal allograft rejection therapy.Front. Biosci. 86, (2022).
Huang, Q. Y. et al. Therapeutic options for premature ovarian insufficiency: an updated review. Reprod. Biol. Endocrinol. 20, 28 (2022).
Na, J. & Kim, G. J. Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review. J. Ovarian Res. 13, 74 (2020).
Li, Z. et al. Human umbilical cord mesenchymal stem cell-derived exosomes improve ovarian function and proliferation of premature ovarian insufficiency by regulating the hippo signaling pathway. Front. Endocrinol. 12, 711902 (2021).
Zhang, L. et al. Human pluripotent stem cell-mesenchymal stem cell-derived exosomes promote ovarian granulosa cell proliferation and attenuate cell apoptosis induced by cyclophosphamide in a POI-like Mouse Model. Molecules. 28, 2112–2129 (2023).
Ding, C. et al. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells. 38, 1137–1148 (2020).
Yang, M. et al. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab. Investig. 100, 342–352 (2020).
Chen, Y. S., Lin, E. Y., Chiou, T. W. & Harn, H. J. Exosomes in clinical trial and their production in compliance with good manufacturing practice. Ci Ji Yi Xue Za Zhi. 32, 113–120 (2020).
Perocheau, D. et al. Clinical applications for exosomes: Are we there yet? Br. J. Pharmacol. 178, 2375–2392 (2021).
Rezaie, J., Feghhi, M. & Etemadi, T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun. Signal. 20, 145 (2022).
Wang, X. et al. Recent progress in exosome research: isolation, characterization and clinical applications. Cancer Gene Ther. 30, 1051–1065 (2023).
Santos, P. & Almeida, F. Exosome-based vaccines: history, current state, and clinical trials. Front. Immunol. 12, 711565 (2021).
Hao, Z. C. Stem cell-derived exosomes: a promising strategy for fracture healing. Cell Prolif. 50, 359–368 (2017).
Yang, Z. L. et al. The role of exosomes and exosomal noncoding RNAs from different cell sources in spinal cord injury. Front. Cell. Neurosci. 16, 882306 (2022).
Hade, M. D., Suire, C. N. & Suo, Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells. 10, 1959–2006 (2021).
Lou, G., Chen, Z., Zheng, M. & Liu, Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp. Mol. Med. 49, e346 (2017).
Krishnan, A., Muthusamy, S., Fernandez, F. B. & Kasoju, N. Mesenchymal stem cell-derived extracellular vesicles in the management of COVID19-associated lung injury: a review on publications, clinical trials and patent landscape. Tissue Eng. Regen. Med. 19, 659–673 (2022).
Tsioulos, G. et al. Insights into CD24 and exosome physiology and potential role in view of recent advances in COVID-19 therapeutics: a narrative review. Life. 12, 1472–1487 (2022).
Yoo, K. H. Possibility of exosome‑based coronavirus disease 2019 vaccine (Review). Mol. Med. Rep. 25, 3625–3633 (2022).
Yassine, S. & Alaaeddine, N. Mesenchymal stem cell exosomes and cancer: controversies and prospects. Adv. Biol. 6, e2101050 (2022).
Vakhshiteh, F., Atyabi, F. & Ostad, S. N. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int. J. Nanomed. 14, 2847–2859 (2019).
Lin, Z. et al. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol. Cancer. 21, 179 (2022).
Xu, Z., Zeng, S., Gong, Z. & Yan, Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol. Cancer. 19, 160 (2020).
Nam, G. H. et al. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv. Mater. 32, e2002440 (2020).
Kim, H. Recent advances in exosome-based drug delivery for cancer therapy. Cancers. 13, 4435–4457 (2021).
Dai, J. et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal. Transduct. Target Ther. 5, 145 (2020).
Nie, L. et al. Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. Cell Death Discov. 9, 215 (2023).
Fernandez-Munoz, B., Garcia-Delgado, A. B., Arribas-Arribas, B. & Sanchez-Pernaute, R. Human neural stem cells for cell-based medicinal products. Cells. 10, 2377–2402 (2021).
Shahbazi, E., Mirakhori, F., Ezzatizadeh, V. & Baharvand, H. Reprogramming of somatic cells to induced neural stem cells. Methods 133, 21–28 (2018).
Ma, Y. et al. Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways. Neurobiol. Dis. 124, 322–334 (2019).
Ma, Y. et al. Induced neural progenitor cell-derived extracellular vesicles promote neural progenitor cell survival via extracellular signal-regulated kinase pathway. CNS Neurosci. Ther. 27, 1605–1609 (2021).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41392-023-01704-0